Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
Gilead researchers say lenacapavir “has the potential to be one of the most impactful interventions” in the battle against HIV.
October 15 2024 5:03 PM
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Gilead researchers say lenacapavir “has the potential to be one of the most impactful interventions” in the battle against HIV.
Things to know about the resurgence of mpox.
300,000 condoms will be available in the Paris Olympic Village, returning to tradition after the IOC issued an intimacy ban and social distancing orders for the 2021 Tokyo Olympics.
It’s called the "syndemic approach" and sexually active people should know about it, health officials say.
On a recent episode of +Talk, two experts relay the real facts about breastfeeding when living with HIV.
A lower court had ruled that requiring PrEP coverage was akin to supporting homosexuality and, therefore, a violation of religious rights. However, advocates are concerned about further legal challenges that may appear.
This Black, queer-led organization is addressing the intersectional challenges their communities face, including HIV.
A new case of sexually transmissible tinea has been reported in New York that can take months to clear up.
A look back on how research and radical activism have worked together to harness the power of U=U.
A new report highlights significant flaws in the federal handling of the mpox outbreak, emphasizing the need for a more unified response system to tackle future public health emergencies.
Experts point to a lag in vaccination rates in addition to other looming new threats.
So much has changed when it comes to injectables — get some clarity here.
A new study found combining treatments could lead to an astounding reduction of HIV transmissions.
Maternal syphilis rates in the U.S. have tripled in recent years, CDC report shows, raising infection risk for infants.
Governor Newsom signed a bill on Tuesday greatly increasing access to the preventative HIV medication.
As cases continue to surge in the U.S., recent federal efforts aim to tackle the alarming trend.
Many scientists are undeterred in the effort to prevent HIV without a lifetime of medication.
We celebrate some of the HIV community's greatest heroes who are smashing stigma and working to eliminate the epidemic once and for all.
Although PEPFAR has saved an estimated 25 million lives over the past 20 years (and was created by a Republican administration), extreme conservatives are attempting to shut it down.
The preferred treatment for syphilis is in short supply, and experts are urging the White House to intervene.